The MedTech Europe Code of Ethical Business Practice which came into force on 1 January 2017 regulates all aspects of the MedTech industry’s relationships with Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs). One important change introduced by the Code which will only be applicable as of 1 January 2018 is discontinuation of direct sponsorship of HCPs. As of that date, independent medical education has to be supported exclusively by means of Educational Grants. Such Educational Grants can be provided to Healthcare Organisations (HCOs) or Professional Congress Organisers (PCOs).
In order to allow these organisations to demonstrate their commitment to the ethical standards included in the Code to the industry partners, MedTech Europe set up the Ethical Charter, which is a voluntary certification initiative.
Why The Ethical Chartered Organization is recommended?
Facilitate timely funding opportunities
The Ethical Charter is one way to address the timely commitment, both for Third Party Congress Organizers and MedTech Europe member companies
Pre-clearance for HCOs and PCOs
In addition, becoming Trusted Partner means being able to benefit from the Conference Vetting System (CVS) of an earlier and swifter provisional assessment, based on a limited number of criteria. For avoidance of doubt, the Event would still need to go through the complete assessment process and obtain an overall assessment decision from CVS.
Benefits for MedTech Europe Member Companies
With a visible symbol of commitment to compliance provided to Trusted Partners, MedTech Europe member companies will have the opportunity to provide early support to Trusted Partner, knowing these are aware of the MedTech Europe Code and committed to organize their Events accordingly.